Haemonetics (HAE) Cash & Current Investments (2009 - 2026)
Haemonetics (HAE) posted quarterly Cash & Current Investments of $245.4 million for Q1 2026, down 19.99% year-over-year from $306.8 million in Q1 2025, and down 32.45% quarter-over-quarter from $363.4 million in Q4 2025.
Haemonetics (HAE) Cash & Current Investments (2009 - 2026) Analysis & Trends
Haemonetics' Cash & Current Investments history runs 18 years deep, the most recent figure standing at $245.4 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 19.99% year-over-year to $245.4 million; the TTM figure through Mar 2026 stood at $245.4 million (down 19.99% YoY), while the FY2026 annual figure was $245.4 million, down 19.99% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $245.4 million, down from $363.4 million in the prior quarter.
- The five-year high for Cash & Current Investments was $363.4 million in Q4 2025, with the low at $178.8 million in Q1 2024.
- The 5-year median for Cash & Current Investments is $285.1 million (2023), against an average of $274.4 million.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 37.15% in 2024, then soared 71.57% in 2025.
- Haemonetics' Cash & Current Investments stood at $224.0 million in 2022, then fell by 13.4% to $194.0 million in 2023, then soared by 65.4% to $320.8 million in 2024, then increased by 13.25% to $363.4 million in 2025, then slumped by 32.45% to $245.4 million in 2026.
- Business Quant data shows HAE's Cash & Current Investments at $245.4 million in Q1 2026, $363.4 million in Q4 2025, and $296.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 223.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 223.38 Mn |
| Mar 28, 2026 | 245.44 Mn |
| Dec 27, 2025 | 363.37 Mn |
| Sep 27, 2025 | 296.43 Mn |
| Jun 28, 2025 | 292.90 Mn |
| Mar 29, 2025 | 306.76 Mn |
| Dec 28, 2024 | 320.85 Mn |
| Sep 28, 2024 | 299.28 Mn |
| Jun 29, 2024 | 344.43 Mn |
| Mar 30, 2024 | 178.80 Mn |
| Dec 30, 2023 | 193.98 Mn |
| Sep 30, 2023 | 351.01 Mn |
| Jul 1, 2023 | 285.72 Mn |
| Apr 1, 2023 | 284.47 Mn |
| Dec 31, 2022 | 224.00 Mn |
| Oct 1, 2022 | 241.20 Mn |
| Jul 2, 2022 | 214.95 Mn |
| Apr 2, 2022 | 259.50 Mn |
| Jan 1, 2022 | 236.88 Mn |
| Oct 2, 2021 | 192.42 Mn |